Table 2.
Comparison between study and control groups in vaspin serum levels and other cardio-metabolic risk variables.
| Cardio-Metabolic Variables | Study Group (n = 70) | Control Group (n = 40) | t Value | 95% CI Upper-Lower Limits | p Value |
|---|---|---|---|---|---|
| Serum cTn-I pg/mL) | 74.54 ± 13.32 | 77.64 ± 12.22 | −0.98 | 3.33–9.53 | 0.33 |
| Serum vaspin(pg/mL) | 603.83 ± 18.13 | 542.75 ± 38.95 | 6.8 | 79.72–42.33 | <0.0001 ** |
| TC (mg/dL) | 199.28 ± 20.49 | 266.43 ± 16.59 | −15.1 | −134.29 | <0.0001 ** |
| TG (mg/dL) | 166.83 ± 17.34 | 254.73 ± 22.82 | −15.95 | −175.78 | <0.0001 ** |
| LDL (mg/dL) | 118.80 ± 8.75 | 164.71 ± 13.59 | −14.28 | −81.81 | <0.0001 ** |
| HDL(mg/dL) | 47.11 ± 9.86 | 50.76 ± 7.34 | −1.8 | 0.43–7.73 | 0.078 |
| VLDL (mg/dL) | 33.36 ± 5.83 | 50.94 ± 6.42 | −11.01 | −35.15 | <0.0001 ** |
| AI | 0.189 ± 0.012 | 0.341 ± 0.021 | −30.95 | −0.3 | <0.0001 ** |
| CRR | 4.23 ± 1.44 | 5.24 ± 1.98 | −2.12 | −2.01 | 0.04 * |
| SBP (mmHg) | 166.54 ± 21.54 | 155.87 ± 19.63 | 2.09 | 21.02–0.31 | 0.043 * |
| DBP (mmHg) | 92.23 ± 22.69 | 87.67 ± 13.75 | 1.11 | 12.78–3.66 | 0.27 |
| FBG (mg/dL) | 101.65 ± 11.93 | 97.87 ± 8.97 | 1.53 | 8.75–1.19 | 0.132 |
| PPG(mg/dL) | 128.64 ± 11.83 | 132.64 ± 12.74 | −1.25 | 2.50–10.50 | 0.21 |
| Hs-CRP (mg/L) | 2.95 ± 0.45 | 4.65 ± 1.84 | −4.09 | −3.39 | 0.0006 ** |
Data presented as mean ± SD, * p < 0.05, ** p < 0.01 versus control; cTn-I: cardiac troponin-I; TG: triglyceride; TC: total cholesterol; LDL: low density lipoprotein; HDL: high density lipoprotein; VLDL: very low density lipoprotein; AI: atherogenic index; CRR: cardiac risk ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; PPG: postprandial glucose; Hs-CRP: highly sensitive CRP.